S&D Co., Ltd (KOSDAQ:260970)
South Korea · Delayed Price · Currency is KRW 48,700
+4,500 (10.18%)
At close: Jun 29, 2026
S&D Co., Ltd Revenue
S&D Co., Ltd had revenue of 45.47B KRW in the quarter ending March 31, 2026, with 27.32% growth. This brings the company's revenue in the last twelve months to 160.69B, up 25.51% year-over-year. In the year 2025, S&D Co., Ltd had annual revenue of 150.94B with 29.96% growth.
Revenue (ttm)
160.69B
Revenue Growth
+25.51%
P/S Ratio
0.88
Revenue / Employee
n/a
Employees
n/a
Market Cap
140.88B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 150.94B | 34.80B | 29.96% |
| Dec 31, 2024 | 116.14B | 27.86B | 31.56% |
| Dec 31, 2023 | 88.28B | 14.96B | 20.40% |
| Dec 31, 2022 | 73.32B | 11.92B | 19.41% |
| Dec 31, 2021 | 61.40B | 4.86B | 8.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sambo Corrugated Board | 543.19B |
| Macrogen | 199.60B |
| Kyung Dong Pharmaceutical | 198.27B |
| CMG Pharmaceutical | 110.12B |
| MEGAELECTRONICS | 96.87B |
| REFINE | 58.04B |
| Yoosung T&S | 57.48B |
| RAON ROBOTICS | 55.84B |
S&D Co., Ltd News
- 6 weeks ago - S&D Co., Ltd Quarterly report: Q1 2026 - Filings
- 3 months ago - S&D Co., Ltd Annual report: Q4 2025 - Filings
- 8 months ago - S&D Co., Ltd Quarterly report: Q3 2025 - Filings
- 11 months ago - S&D Co., Ltd Quarterly report: Q2 2025 - Filings